The Valley Desk

ArticleJAAD internationalPublished

Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
JAAD international
Published
Subject terms
prurigo nodularis; Dermatology Life Quality Index (Dlqi); Dupilumab; Investigator’s Global Assessment For Prurigo Nodularis Stage (Iga Pn-s); Worst Itch Numerical Rating Scale (Wi-nrs)
PubMed ID
39006917
PubMed Central ID
PMC11246003
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal